Escalon Medical Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Escalon Medical Corp. generated cash of -$602,771, which is less than the previous year. Cash used in financing activities reached the amount of -$37,456 last year. Net change in cash is therefore -$680,512.
Cash Flow
| 2015 | -456.53K | -36.25K | 0 |
|---|---|---|---|
| 2016 | -1.19M | -56.64K | 275K |
| 2017 | -505.99K | -8K | 520K |
| 2018 | 106.73K | 458.14K | -235K |
| 2019 | -472.68K | -22.11K | 33.68K |
| 2020 | -168.49K | -59.75K | 646.60K |
| 2021 | 838.70K | -9.39K | -3.66K |
| 2022 | -1.04M | 0 | -6.93K |
| 2023 | 325.14K | -13.84K | -15.37K |
| 2024 | -602.77K | -40.28K | -37.45K |
ESMC Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.14M | 850.03K | 1.90M | 1.08M | 662.87K | 1.12M | 544.11K | 538.11K | 1.51M | 2.00M |
Operating activities | ||||||||||
Net income | -125.26K | 456.82K | 18.08K | -52.02K | -650.28K | -250.01K | 583.67K | -726.89K | -1.15M | -1.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 46.01K | 45.20K | 48.43K | 44.81K | 50.08K | 50.13K | 49.21K | 45.91K | 24.65K | 14.30K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72.04K | 67.36K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 72.04K | 67.36K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -454.01K | -229.97K | -615.31K | 221.23K | 171.16K | -103.52K | 149.82K | 130.77K | 171.37K | -95.77K |
Inventories | -24.47K | -44.03K | -187.22K | 368.30K | 93.83K | -55.44K | -19.47K | 189.21K | -63.53K | 691.11K |
Accounts payable | 151.71K | 193.05K | -89.67K | 341.50K | 94.11K | 137.66K | -221.52K | -305.53K | -254.86K | -82.39K |
Cash generated by operating activities | -602.77K | 325.14K | -1.04M | 838.70K | -168.49K | -472.68K | 106.73K | -505.99K | -1.19M | -456.53K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -40.28K | -13.84K | 0 | -9.39K | -59.75K | -22.11K | -41.85K | -8K | -56.64K | -36.25K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -40.28K | -13.84K | 0 | -9.39K | -59.75K | -22.11K | 458.14K | -8K | -56.64K | -36.25K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -37.45K | -15.37K | -6.93K | -3.66K | -3.39K | 33.68K | -85K | 520K | 0 | 0 |
Cash used in financing activities | -37.45K | -15.37K | -6.93K | -3.66K | 646.60K | 33.68K | -235K | 520K | 275K | 0 |
Net Change In Cash | -680.51K | 295.93K | -1.05M | 825.65K | 418.36K | -461.12K | 329.88K | 6.00K | -978.64K | -492.79K |
Cash at end of period | 465.45K | 1.14M | 850.03K | 1.90M | 1.08M | 662.87K | 874.00K | 544.11K | 538.11K | 1.51M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |